Carotenuto, Antonio http://orcid.org/0000-0002-1574-9693
De Giglio, Laura
Chiodi, Alessandro
Petracca, Maria
Rosa, Laura
Bianchi, Maurizio
Ferrante, Ilaria
Lauro, Francesca
Moccia, Marcello
Ianniello, Antonio
Pozzilli, Carlo
Brescia Morra, Vincenzo
Lanzillo, Roberta
Article History
Received: 8 September 2020
Accepted: 29 October 2020
First Online: 21 November 2020
Compliance with ethical standards
:
: Antonio Carotenuto received research grants from ALMIRALL, and honoraria form Novartis, Merck and Biogen. Marcello Moccia has received research grants from ECTRIMS-MAGNIMS, UK MS Society and Merck; honoraria from Biogen, Merck, Novartis and Roche; and consulting fees from Veterans Evaluation Services. Roberta Lanzillo received personal compensations for speaking or consultancy from Biogen, Teva, Genzyme, Merck, Novartis, Almirall. Maria Petracca received travel grant from Novartis. Vincenzo Brescia Morra received personal compensations for speaking or consultancy from Biogen, Teva, Genzyme, Merck, Novartis, Almirall. Chiodi Alessandro, Laura Rosa, Bianchi Maurizio, Francesca Lauro, Ilaria Ferrante and Ianniello Antonio declare no potential conflicts of interest with respect to the research, authorship and/or publication of this abstract. Carlo Pozzilli received consulting and lecture fees and research funding and travel grants from Almirall, Bayer, Biogen, Genzyme, Merck Serono, Novartis, Roche and Teva. Laura Del Giglio received speaking honoraria from Genzyme and Novartis; travel grants from Biogen, Merk and Teva; and consulting fees from Genzyme, Merk, and Novartis.
: The study was approved by the Institutional Review Board of the University of Naples ‘Federico II’ and of the ‘S. Andrea’ Hospital in Rome and all investigators adhered to the tenets of the Declaration of Helsinki.
: Written informed consents were obtained from all subjects enrolled in the study.